AMNIOSTRATIS Trademark

Trademark Overview

On Tuesday, July 23, 2019, a trademark application was filed for AMNIOSTRATIS with the United States Patent and Trademark Office. The USPTO has given the AMNIOSTRATIS trademark a serial number of 88530335. The federal status of this trademark filing is REGISTERED as of Tuesday, August 17, 2021. This trademark is owned by Vivex Biologics, Inc.. The AMNIOSTRATIS trademark is filed in the Pharmaceutical Products category with the following description:

Biological amniotic tissue intended for subsequent implantation
amniostratis

General Information

Serial Number88530335
Word MarkAMNIOSTRATIS
Filing DateTuesday, July 23, 2019
Status700 - REGISTERED
Status DateTuesday, August 17, 2021
Registration Number6456347
Registration DateTuesday, August 17, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2019

Trademark Statements

Goods and ServicesBiological amniotic tissue intended for subsequent implantation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2019
Primary Code005
First Use Anywhere DateSunday, February 23, 2020
First Use In Commerce DateSunday, February 23, 2020

Trademark Owner History

Party NameVIVEX BIOLOGICS GROUP, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMiami, FL 33167
US
Party NameVIVEX BIOLOGICS GROUP, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressATLANTA, GA 30339
US
Party NameVIVEX BIOLOGICS GROUP, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressATLANTA, GA 30339
US
Party NameVivex Biologics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339
US

Trademark Events

Event DateEvent Description
Friday, July 26, 2019NEW APPLICATION ENTERED
Wednesday, July 31, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 21, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, August 30, 2019ASSIGNED TO EXAMINER
Wednesday, September 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 8, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 18, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, June 18, 2020TEAS PETITION TO REVIVE RECEIVED
Thursday, June 18, 2020PETITION TO REVIVE-GRANTED
Thursday, June 18, 2020SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, June 18, 2020NOTICE OF REVIVAL - E-MAILED
Thursday, July 30, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 3, 2020SOU EXTENSION 1 FILED
Thursday, July 30, 2020SOU EXTENSION 1 GRANTED
Friday, July 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 4, 2020TEAS PETITION TO REVIVE RECEIVED
Friday, December 4, 2020PETITION TO REVIVE-GRANTED
Friday, December 4, 2020SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, December 4, 2020NOTICE OF REVIVAL - E-MAILED
Thursday, December 3, 2020SOU EXTENSION 2 FILED
Monday, December 7, 2020SOU EXTENSION 2 GRANTED
Tuesday, December 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 6, 2021TEAS STATEMENT OF USE RECEIVED
Thursday, May 6, 2021USE AMENDMENT FILED
Monday, May 10, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 11, 2021SU - NON-FINAL ACTION - WRITTEN
Tuesday, May 11, 2021NON-FINAL ACTION E-MAILED
Tuesday, May 11, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 24, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 8, 2021ASSIGNED TO LIE
Tuesday, July 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 13, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 14, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 17, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, March 25, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 25, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 25, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 25, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 25, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

amniostratis subsequent implantation intended tissue amniotic biological